NEW YORK (GenomeWeb News) - Bionas and PRIMACYT said today that they will jointly develop a cell-based assay using human liver cells to predict hepatotoxic effects of drugs and chemicals.
 
PRIMACYT, based in Schwerin, Germany, will supply the hepatocytes. The hepatocytes will be cultivated on Bionas metabolic chips with chemically defined media from PRIMACYT.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.